Prosight Management, LP Abb Vie Inc. Transaction History

Prosight Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $2.66 Million - $3.37 Million	-24,800 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $2.64 Million - $3 Million	24,800 New	24,800 $2.68 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $1.18 Million - $1.57 Million	-16,030 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $1.03 Million - $1.57 Million	16,030 New	16,030 $1.22 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $2.81 Million - $3.52 Million	-39,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $2.46 Million - $2.95 Million	39,000 New	39,000 $2.95 Million

3,852

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

Stay updated on Prosight Management, LP with notifications on news.